Literature DB >> 2900562

[Cardiovascular effects of timolol, carteolol, metipranolol, betaxolol collyres in the aged patient].

C Le Jeunne, L Bringer, Z Mondjee-Tahura, Y Munera, F C Hugues.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2900562

Source DB:  PubMed          Journal:  Therapie        ISSN： 0040-5957            Impact factor:   2.070


× No keyword cloud information.
  5 in total

Review 1.  Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertension.

Authors:  P Chrisp; E M Sorkin
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

Review 2.  Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension.

Authors:  M M Buckley; K L Goa; S P Clissold
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

Review 3.  Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension.

Authors:  Sheridan Henness; Tracy Swainston Harrison; Gillian M Keating
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 4.  Systemic and local tolerability of ophthalmic drug formulations. An update.

Authors:  F C Hugues; C Le Jeunne
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

5.  A 3-month comparison of 1% and 2% carteolol and 0.5% timolol in open-angle glaucoma.

Authors:  W C Stewart; M B Shields; R C Allen; R A Lewis; J S Cohen; H D Hoskins; J N Hetherington; R L Bahr; J E Noblin; J T Delehanty
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.